scholarly article | Q13442814 |
P356 | DOI | 10.3233/JAD-140669 |
P698 | PubMed publication ID | 26599049 |
P50 | author | Simon Lovestone | Q30582986 |
Iwona Kłoszewska | Q38633661 | ||
Hilkka Soininen | Q38636823 | ||
Patrizia Mecocci | Q46713839 | ||
Mizanur Khondoker | Q47163880 | ||
Petroula Proitsi | Q47504060 | ||
Magda N. Tsolaki | Q57073392 | ||
Bruno Vellas | Q66877204 | ||
Martina Sattlecker | Q114432270 | ||
P2093 | author name string | Stephen Williams | |
Richard Jb Dobson | |||
P2860 | cites work | Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 |
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists | Q28131785 | ||
Inflammation and Alzheimer's disease | Q28138617 | ||
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis | Q28217930 | ||
Aptamer-based multiplexed proteomic technology for biomarker discovery | Q28744329 | ||
Plasma based markers of [11C] PiB-PET brain amyloid burden | Q34427001 | ||
Proteome-based plasma biomarkers for Alzheimer's disease | Q34577503 | ||
A serum protein-based algorithm for the detection of Alzheimer disease | Q34755504 | ||
Inflammatory proteins in plasma are associated with severity of Alzheimer's disease | Q34769550 | ||
Decreased serum albumin levels in Taiwanese patients with schizophrenia | Q35027007 | ||
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease | Q35034130 | ||
A blood-based algorithm for the detection of Alzheimer's disease | Q35203409 | ||
Lower residual renal function is a risk factor for depression and impaired health-related quality of life in Korean peritoneal dialysis patients | Q35639050 | ||
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease | Q36183810 | ||
Chemokines and brain functions | Q36230513 | ||
Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide | Q36401494 | ||
Role of complement in neurodegeneration and neuroinflammation. | Q36477580 | ||
Multiple actions of the chemokine stromal cell-derived factor-1alpha on neuronal activity | Q36752538 | ||
Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins | Q36927870 | ||
Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease | Q36932748 | ||
Biological marker candidates of Alzheimer's disease in blood, plasma, and serum. | Q37617521 | ||
Plasma biomarkers for Alzheimer's disease: much needed but tough to find | Q38037157 | ||
Parkinson's disease plasma biomarkers: an automated literature analysis followed by experimental validation. | Q38079416 | ||
Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains | Q39654001 | ||
The conformation of Alzheimer's beta peptide determines the rate of amyloid formation and its resistance to proteolysis | Q42126660 | ||
Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. | Q44597455 | ||
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins | Q44917427 | ||
Decreased plasma antioxidants in schizophrenia | Q44922740 | ||
Serum levels of pregnancy zone protein are elevated in presymptomatic Alzheimer's disease | Q45892444 | ||
Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease | Q46155330 | ||
Blood-based protein biomarkers for diagnosis of Alzheimer disease | Q47378944 | ||
Reduced plasma antioxidants in first-episode patients with schizophrenia | Q47789195 | ||
Serum amyloid P component induces neuronal apoptosis and β-amyloid immunoreactivity | Q48183927 | ||
Biomarkers in brain disease. Preface | Q48411055 | ||
C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease | Q48796828 | ||
Total serum protein and serum protein fractions in depression: relationships to depressive symptoms and glucocorticoid activity | Q48822082 | ||
Serum IL-6, albumin and co-morbidities are closely correlated with symptoms of depression in patients on maintenance haemodialysis | Q49128065 | ||
Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology. | Q50646784 | ||
Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio. | Q51736251 | ||
Immunodetection of the amyloid P component in Alzheimer's disease. | Q53187403 | ||
Abnormal serum concentrations of proteins in Parkinson's disease. | Q53497967 | ||
P433 | issue | 4 | |
P921 | main subject | blood plasma | Q79749 |
P304 | page(s) | 1105-1114 | |
P577 | publication date | 2015-11-23 | |
P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
P1476 | title | Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease. | |
P478 | volume | 49 |
Q51760901 | A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication. |
Q93080662 | Alterations in Alzheimer's Disease-Associated Gene Expression in Severe Obstructive Sleep Apnea Patients |
Q54982684 | Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease. |
Q63977287 | Aptamer-Based Proteomics Identifies Mortality-Associated Serum Biomarkers in Dialysis-Dependent AKI Patients |
Q60950950 | Blood-Derived Plasma Protein Biomarkers for Alzheimer's Disease in Han Chinese |
Q64108130 | Blood-based molecular biomarkers for Alzheimer's disease |
Q93080975 | Fine-Mapping of the Human Blood Plasma N-Glycome onto Its Proteome |
Q92436802 | Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition |
Q60045873 | Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease |
Search more.